Showing results (351-360 of 436) with videos related to

Sort By:
Pageof 44
The Journal of Infectious Diseases|July 11, 2008
Thymosin alpha1- and ulinastatin-based immunomodulatory strategy for sepsis arising from intra-abdominal infection due to carbapenem-resistant bacteriaYing Zhang, Hao Chen, Yu-min Li, et al.
Chinese Medical Journal|September 8, 2010
Coagulase-negative staphylococcus and enterococcus as predominant pathogens in liver transplant recipients with Gram-positive coccal bacteremiaShao-hua Shi, Hai-shen Kong, Chang-ku Jia, et al.
The Journal of International Medical Research|April 10, 2013
Recipient IL-6-572C/G genotype is associated with reduced incidence of acute rejection following liver transplantationJia Yao, Xiao-Wen Feng, Xiao-Bo Yu, et al.
Clinical Transplantation|January 6, 2010
Risk factors for pneumonia caused by multidrug-resistant Gram-negative bacilli among liver recipientsShao Hua Shi, Hai Shen Kong, Chang Ku Jia, et al.
American Journal of Translational Research|July 14, 2020
Endoplasmic reticulum stress triggers delanzomib-induced apoptosis in HCC cells through the PERK/eIF2α/ATF4/CHOP pathwayJun Li, Jian-Yong Zhuo, Wei Zhou, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|February 12, 2023
Older liver grafts from donation after circulatory death are associated with impaired survival and higher incidence of biliary non-anastomotic strictureTian Shen, Shan-Hua Zheng, Jun Chen, et al.
World Journal of Surgical Oncology|April 4, 2016
Porta hepatic schwannoma: case report and a 30-year review of the literature yielding 15 casesSheng-yong Yin, Zheng-long Zhai, Kui-wu Ren, et al.
International Journal of Medical Sciences|February 12, 2014
Role of overexpression of MACC1 and/or FAK in predicting prognosis of hepatocellular carcinoma after liver transplantationSheng Gao, Bing-Yi Lin, Zhe Yang, et al.
Zhonghua Yi Xue Za Zhi|February 23, 2007
[Dual, triple, and quadruple oral tacrolimus-based immunosuppression regimens after orthotopic liver transplantation: a randomised comparative study of regimens]An-wei Lu, Shu-sen Zheng, Jian Wu, et al.
Frontiers in Cellular and Infection Microbiology|October 1, 2025
Application of probiotic therapy in nonalcoholic fatty liver disease: mediating mechanism and future perspectiveXing-Yu Luo, Wei-Bin Huang, Chuang-Hui Lu, et al.
Pageof 44